Who is sponsoring NCT04225143?

NCT04225143 is sponsored by University Hospital, Caen.

What drugs are being tested in NCT04225143?

Interventions in NCT04225143: urostim bilateral, urostim unilateral.

What condition does NCT04225143 study?

NCT04225143 studies Neurogenic Urinary Bladder, Spastic.

Is NCT04225143 still recruiting?

NCT04225143 is currently status unknown. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT04225143: UROSTIM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bilateral vs. Unilateral Stimulation in Neurological Bladder Disroders

Status unknown NA Last updated 13 January 2020

What this trial tests

NA trial testing urostim bilateral in Neurogenic Urinary Bladder, Spastic in 50 participants. Status unknown.

Timeline

27 November 2019

Primary endpoint
31 October 2020

31 October 2021

Quick facts

Lead sponsor	University Hospital, Caen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	27 November 2019
Primary completion	31 October 2020
Estimated completion	31 October 2021
Sites	1 location across France

Drugs / interventions tested

urostim bilateral
urostim unilateral

Conditions studied

Neurogenic Urinary Bladder, Spastic — all drugs for Neurogenic Urinary Bladder, Spastic →

Sponsor

University Hospital, Caen

Who can join

18 and older, any sex, with Neurogenic Urinary Bladder, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effectiveness of bilateral stimulation of the tibial nerve compared to unilateral stimulation in neurological bladder disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Caen trials

Trials by the same sponsor.

NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04225143 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04225143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing